GlassScriptPhysician profile
Pamela J Goodwin
NPI 1700878857
$3,750.63
in general payments reported to CMS, 2019-2025
36 companies · $528 in 2025
The $528 reported for 2025 was more than what 82% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $344 · 2020: $397 · 2021: $445 · 2022: $912 · 2023: $496 · 2024: $628 · 2025: $528.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,652.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,652.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $525.55 | 2019-2024 | |
| Mayne Pharma Commercial LLC | $414.10 | 2021-2025 | |
| Sumitomo Pharma America, INC. | $321.80 | 2023-2025 | Myfembree, Gemtesa |
| Astellas Pharma US INC | $271.36 | 2023-2025 | Veozah |
| Aspira Women'S Health INC | $261.23 | 2021-2022 | |
| Myovant Sciences INC. | $252.77 | 2021-2022 | |
| Exeltis, USA INC. | $233.57 | 2020-2025 | Slynd |
| Coopersurgical, INC. | $181.17 | 2019-2024 | Paragard T 380a, Paragard T 380a, Wallach Cryosurgical Equipment |
| Therapeuticsmd, INC. | $150.64 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $105.67 | 2019-2025 | |
| Agile Therapeutics, INC. | $103.88 | 2021-2024 | Twirla |
| Dysis Medical, INC. | $90.52 | 2019-2020 | |
| Evofem Biosciences, INC. | $81.09 | 2021-2022 | |
| Pfizer INC. | $75.64 | 2023-2024 | |
| Avion Pharmaceuticals | $72.49 | 2020-2023 | Balcoltra |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $64.41 | 2023 | Cologuard Collection Kit |
| Medtronic, INC. | $59.35 | 2024-2025 | Truclear |
| Scynexis, INC. | $45.00 | 2022 | |
| Hologic Sales and Service, LLC | $43.79 | 2025 | Myosure Tissue Removal Device, Novasure |
| Biogen, INC. | $40.90 | 2025 | Zurzuvae |
| Lupin INC. | $36.13 | 2019-2020 | |
| Vertical Pharmaceuticals, LLC | $34.77 | 2019-2020 | |
| Allergan, INC. | $32.56 | 2020 | |
| Sanofi Pasteur INC. | $29.13 | 2024 | |
| Amgen INC. | $27.19 | 2019 | |
| Becton, Dickinson and Company | $25.92 | 2023 | Bd Onclarity |
| Daiichi Sankyo INC. | $23.53 | 2020 | |
| Pacira Pharmaceuticals Incorporated | $22.53 | 2019 | |
| Shield Therapeutics INC | $21.82 | 2024 | |
| Avanos Medical | $18.62 | 2022 | |
| Ascend Therapeutics US, LLC | $16.45 | 2023 | |
| Smith+Nephew, INC. | $16.18 | 2020 | |
| Minerva Surgical, INC | $13.23 | 2022 | |
| Mission Pharmacal Company | $13.19 | 2019 | |
| Merck Sharp & Dohme LLC | $13.02 | 2019 | |
| Covidien LP | $11.43 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Pamela Goodwin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.